Impact of Invasive Pulmonary Aspergillosis in Critically Ill Surgical Patients with or without Solid Organ Transplantation

被引:3
作者
Dubler, Simon [1 ,2 ]
Etringer, Michael [1 ]
Weigand, Markus A. [1 ,3 ,4 ]
Brenner, Thorsten [2 ]
Zimmermann, Stefan [5 ]
Schnitzler, Paul [6 ]
Budeus, Bettina [7 ]
Rengier, Fabian [3 ,4 ,8 ]
Kalinowska, Paulina [3 ,4 ,8 ]
Hoo, Yuan Lih [1 ]
Lichtenstern, Christoph [1 ]
机构
[1] Heidelberg Univ Hosp, Dept Anaesthesiol, D-69120 Heidelberg, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Anesthesiol & Intens Care Med, D-45147 Essen, Germany
[3] Heidelberg Univ, Translat Lung Res Ctr Heidelberg TLRC, D-69120 Heidelberg, Germany
[4] Heidelberg Univ, German Ctr Lung Res DZL, D-69120 Heidelberg, Germany
[5] Heidelberg Univ Hosp, Dept Infect Dis Med Microbiol & Hyg, Div Bacteriol, D-69120 Heidelberg, Germany
[6] Heidelberg Univ Hosp, Dept Infect Dis Virol, D-69120 Heidelberg, Germany
[7] Univ Duisburg Essen, Inst Cell Biol Canc Res, D-45147 Essen, Germany
[8] Heidelberg Univ Hosp, Clin Diagnost & Intervent Radiol, D-69120 Heidelberg, Germany
关键词
aspergillosis; solid organ transplantation; critical care; intensive care unit; immunosuppression; FUNGAL-INFECTIONS; EPIDEMIOLOGY; DEFINITIONS; PERFORMANCE; DIAGNOSIS;
D O I
10.3390/jcm12093282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Critically ill patients, especially those who have undergone solid organ transplantation (SOT), are at risk of invasive pulmonary aspergillosis (IPA). The outcome relevance of adequately treated putative IPA (pIPA) is a matter of debate. The aim of this study is to assess the outcome relevance of pIPA in a cohort of critically ill patients with and without SOT. Methods: Data from 121 surgical critically ill patients with pIPA (n = 30) or non-pIPA (n = 91) were included. Cox regression analysis was used to identify risk factors for mortality and unfavourable outcomes after 28 and 90 days. Results: Mortality rates at 28 days were similar across the whole cohort of patients (pIPA: 31% vs. non-pIPA: 27%) and did not differ in the subgroup of patients after SOT (pIPA: 17% vs. non-pIPA: 22%). A higher Sequential Organ Failure Assessment (SOFA) score and evidence of bacteraemia were identified as risk factors for mortality and unfavourable outcome, whereas pIPA itself was not identified as an independent predictor for poor outcomes. Conclusions: Adequately treated pIPA did not increase the risk of death or an unfavourable outcome in this mixed cohort of critically ill patients with or without SOT, whereas higher disease severity and bacteraemia negatively affected the outcome.
引用
收藏
页数:12
相关论文
共 40 条
  • [1] Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study
    Bartoletti, Michele
    Pascale, Renato
    Cricca, Monica
    Rinaldi, Matteo
    Maccaro, Angelo
    Bussini, Linda
    Fornaro, Giacomo
    Tonetti, Tommaso
    Pizzilli, Giacinto
    Francalanci, Eugenia
    Giuntoli, Lorenzo
    Rubin, Arianna
    Moroni, Alessandra
    Ambretti, Simone
    Trapani, Filippo
    Vatamanu, Oana
    Ranieri, Vito Marco
    Castelli, Andrea
    Baiocchi, Massimo
    Lewis, Russell
    Giannella, Maddalena
    Viale, Pierluigi
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E3606 - E3614
  • [2] Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis
    Bassetti, M.
    Giacobbe, D. R.
    Grecchi, C.
    Rebuffi, C.
    Zuccaro, V.
    Scudeller, L.
    [J]. JOURNAL OF INFECTION, 2020, 81 (01) : 131 - 146
  • [3] Intensive care medicine research agenda on invasive fungal infection in critically ill patients
    Bassetti, Matteo
    Garnacho-Montero, Jose
    Calandra, Thierry
    Kullberg, Bartjan
    Dimopoulos, George
    Azoulay, Elie
    Chakrabarti, Arunaloke
    Kett, Daniel
    Leon, Cristobal
    Ostrosky-Zeichner, Luis
    Sanguinetti, Maurizio
    Timsit, Jean-Francois
    Richardson, Malcom D.
    Shorr, Andrew
    Cornely, Oliver A.
    [J]. INTENSIVE CARE MEDICINE, 2017, 43 (09) : 1225 - 1238
  • [4] Diagnosing invasive pulmonary aspergillosis in ICU patients: putting the puzzle together
    Blot, Stijn
    Rello, Jordi
    Koulenti, Despoina
    [J]. CURRENT OPINION IN CRITICAL CARE, 2019, 25 (05) : 430 - 437
  • [5] A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
    Blot, Stijn I.
    Taccone, Fabio Silvio
    Van den Abeele, Anne-Marie
    Bulpa, Pierre
    Meersseman, Wouter
    Brusselaers, Nele
    Dimopoulos, George
    Paiva, Jose A.
    Misset, Benoit
    Rello, Jordi
    Vandewoude, Koenraad
    Vogelaers, Dirk
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (01) : 56 - 64
  • [6] Performance of MALDI-TOF MS platforms for fungal identification
    Cassagne, Carole
    Normand, Anne-Cecile
    L'Ollivier, Coralie
    Ranque, Stephane
    Piarroux, Renaud
    [J]. MYCOSES, 2016, 59 (11) : 678 - 690
  • [7] Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)
    Chakrabarti, Arunaloke
    Kaur, Harsimran
    Savio, Jayanthi
    Rudramurthy, Shivaprakash M.
    Patel, Atul
    Shastri, Prakash
    Pamidimukkala, Umabala
    Karthik, Rajiv
    Bhattacharya, Sanjay
    Kindo, Anupma Jyoti
    Bhattacharya, Pradip
    Todi, Subhash
    Gopalakrishan, Ram
    Singh, Pankaj
    Pandey, Abhishek
    Agarwal, Ritesh
    [J]. JOURNAL OF CRITICAL CARE, 2019, 51 : 64 - 70
  • [8] Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
    De Pauw, Ben
    Walsh, Thomas J.
    Donnelly, J. Peter
    Stevens, David A.
    Edwards, John E.
    Calandra, Thierry
    Pappas, Peter G.
    Maertens, Johan
    Lortholary, Olivier
    Kauffman, Carol A.
    Denning, David W.
    Patterson, Thomas F.
    Maschmeyer, Georg
    Bille, Jacques
    Dismukes, William E.
    Herbrecht, Raoul
    Hope, William W.
    Kibbler, Christopher C.
    Kullberg, Bart Jan
    Marr, Kieren A.
    Munoz, Patricia
    Odds, Frank C.
    Perfect, John R.
    Restrepo, Angela
    Ruhnke, Markus
    Segal, Brahm H.
    Sobel, Jack D.
    Sorrell, Tania C.
    Viscoli, Claudio
    Wingard, John R.
    Zaoutis, Theoklis
    Bennett, John E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) : 1813 - 1821
  • [9] Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock-Results of a Combined Clinical and Experimental Investigation
    Decker, Sebastian O.
    Sigl, Annette
    Grumaz, Christian
    Stevens, Philip
    Vainshtein, Yevhen
    Zimmermann, Stefan
    Weigand, Markus A.
    Hofer, Stefan
    Sohn, Kai
    Brenner, Thorsten
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [10] Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
    Denning, David W.
    Marr, Kieren A.
    Lau, Wendi M.
    Facklam, David P.
    Ratanatharathorn, Voravit
    Becker, Cornelia
    Ullmann, Andrew J.
    Seibel, Nita L.
    Flynn, Patricia M.
    van Burik, Jo-Anne H.
    Buell, Donald N.
    Patterson, Thomas F.
    [J]. JOURNAL OF INFECTION, 2006, 53 (05) : 337 - 349